Evidence to Support Inclusion of Pharmacogenetic Biomarkers in Randomised Controlled Trials. (2019)

First Author: Johnson D
Attributed to:  North West HTMR funded by MRC


No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/jpm9030042

PubMed Identifier: 31480618

Publication URI: http://europepmc.org/abstract/MED/31480618

Type: Journal Article/Review

Volume: 9

Parent Publication: Journal of personalized medicine

Issue: 3

ISSN: 2075-4426